Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer

Background: Bladder cancer (BLCA) ranks 10th in incidence among malignant tumors and 6th in incidence among malignant tumors in males. With the application of immune therapy, the overall survival (OS) rate of BLCA patients has greatly improved, but the 5-year survival rate of BLCA patients is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Bingqi, Liang, Jiaming, Li, Ding, Song, Wenping, Zhao, Shiming, Ma, Yongkang, Song, Jinbo, Zhu, Mingkai, Yang, Tiejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429908/
https://www.ncbi.nlm.nih.gov/pubmed/34512722
http://dx.doi.org/10.3389/fgene.2021.696912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429908/
https://www.ncbi.nlm.nih.gov/pubmed/34512722
http://dx.doi.org/10.3389/fgene.2021.696912

Ejemplares similares